Natco Pharma Ltd.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘Listing Regulations’), NATCO Pharma has informed that ICRA vide their letter No. ICRA/Natco Pharma Limited/28112025/2 dated November 28, 2025 has reaffirmed/assigned the credit ratings of the Company, which are enclosed. Copy of aforesaid letter issued by ICRA Limited is also enclosed as Annexure.

The above information is a part of company’s filings submitted to BSE.